当前位置:首页 - 行情中心 - 科华生物(002022) - 财务分析

科华生物

(002022)

  

流通市值:30.70亿  总市值:30.71亿
流通股本:5.14亿   总股本:5.14亿

科华生物(002022)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润-0.43亿元,每股收益-0.09元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益305063.73万元,未分配利润166189.30万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产454672.80万元,负债149609.07万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入395,096,525.161,642,485,860.081,191,260,566.76793,574,870.31
营业总成本437,618,477.312,015,713,933.661,395,129,544.97907,300,284.93
其他经营收益
营业利润-41,792,380.14-808,227,334.24-250,732,621.08-135,431,919.61
利润总额-42,161,046.89-812,114,481.91-251,753,774.58-135,737,298.48
净利润-43,401,483.61-884,793,893.44-253,819,970.95-140,116,685.34
每股收益
其他综合收益-12,048,291.4919,571,301.3525,828,113.6629,352,996.43
综合收益总额-55,449,775.1-865,222,592.09-227,991,857.29-110,763,688.91
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计2,337,116,089.492,407,157,950.452,716,522,275.752,739,327,678.5
非流动资产:
非流动资产合计2,209,611,955.962,234,277,271.42,453,684,802.062,478,322,810.51
资产总计4,546,728,045.454,641,435,221.855,170,207,077.815,217,650,489.01
流动负债:
流动负债合计1,321,893,917.031,352,640,455.041,230,500,772.37917,610,724.7
非流动负债:
非流动负债合计174,196,793.38179,242,295.98192,949,877.55438,905,158.24
负债合计1,496,090,710.411,531,882,751.021,423,450,649.921,356,515,882.94
所有者权益(或股东权益):
归属于母公司股东权益合计2,577,979,876.952,637,914,841.013,143,739,195.843,245,747,305.82
股东权益合计3,050,637,335.043,109,552,470.833,746,756,427.893,861,134,606.07
负债和股东权益合计4,546,728,045.454,641,435,221.855,170,207,077.815,217,650,489.01
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计389,658,281.241,917,813,770.311,408,569,868.23905,380,295.8
经营活动现金流出小计492,021,339.011,895,375,104.931,432,666,849.58956,376,936.51
经营活动产生的现金流量净额-102,363,057.7722,438,665.38-24,096,981.35-50,996,640.71
投资活动产生的现金流量:
投资活动现金流入小计63,629,672.311,638,264.317,309,152.335,150,390.88
投资活动现金流出小计23,922,356.82199,293,855.3896,368,018.8365,131,594.22
投资活动产生的现金流量净额39,707,315.48-187,655,591.07-89,058,866.5-59,981,203.34
筹资活动产生的现金流量:
筹资活动现金流入小计134,496,697.9651,173,920.12380,789,640.48295,372,654.86
筹资活动现金流出小计127,856,344.28493,892,821.5259,619,517.57233,018,091.32
筹资活动产生的现金流量净额6,640,353.62157,281,098.62121,170,122.9162,354,563.54
汇率变动对现金及现金等价物的影响-1,320,334.43732,215.21-606,958.05584,918.12
现金及现金等价物净增加额-57,335,723.1-7,203,611.867,407,317.01-48,038,362.39
期末现金及现金等价物余额795,837,922.96853,173,646.06867,784,574.93812,338,895.53
补充资料:
现金及现金等价物的净增加额--7,203,611.86--48,038,362.39
TOP↑